Between express diets that promise spectacular results and increasingly publicized medical approaches, measuring what actually works for sustainable weight loss requires comparing strategies based on concrete criteria: maintenance of results over time, impact on muscle mass, and risk of weight regain.
Restrictive diet, dietary rebalancing, or anti-obesity medication: the value of the approaches
Weight loss strategies are not all equal over time. A severe low-calorie diet, a gradual dietary rebalancing, and a drug treatment with GLP-1 agonists follow very different logics.
| Criterion | Restrictive diet | Dietary rebalancing | GLP-1 agonist (medical setting) |
|---|---|---|---|
| Initial weight loss | Rapid | Gradual | Variable depending on the profile |
| Long-term maintenance | Low (frequent yo-yo effect) | High if habits are established | Requires multi-year follow-up |
| Risk of muscle loss | High | Low | Moderate without physical activity |
| Side effects | Fatigue, deficiencies | None if balanced | Digestive issues, monitoring required |
| Patient autonomy | Total | Total | Depends on a prescription |
This table highlights a clear gap: the speed of initial weight loss does not predict weight maintenance. Restrictive diets generate rapid loss but expose individuals to almost systematic regain, often with a surplus compared to the starting weight.
On the medication side, French recommendations are clear. Semaglutide and tirzepatide are not stand-alone solutions. They are part of a comprehensive medical pathway, after nutritional management alone has proven insufficient, with adapted diet, physical activity, and monitoring of side effects. This framework was reaffirmed in 2026 in French recommendations. Dietary rebalancing remains the strategy that offers the best efficacy-safety ratio for the majority of profiles.
To delve deeper into daily nutritional adjustments, the weight loss tips on Mon Assiette detail concrete pathways tailored to different objectives.
Adapted physical activity: an underestimated lever in the care pathway
Recent French recommendations position adapted physical activity as an integral component of the care pathway for adult overweight and obesity, not just as a simple hygiene-dietary advice.
This distinction changes the game. For people with obesity or functional limitations, adapted physical activity programs occupy an increasing place in the French healthcare system. In practical terms, this means that exercise is no longer relegated to the end of a dietary consultation.
What this changes in daily practice
Integrating physical activity as care, rather than as an option, requires structuring it. Three key points emerge from the recommendations:
- Engage in regular activity suited to one’s abilities, including in cases of joint or respiratory limitations, with supervision if necessary.
- Prioritize activities that preserve muscle mass (strength training, active walking, swimming) rather than isolated intense cardio sessions.
- Consider physical activity as a medical follow-up element to be regularly reassessed, just like diet.
However, a common mistake remains compensating for exercise with higher caloric intake, which negates the metabolic benefit. Physical activity primarily affects body composition and hormonal regulation, not just gross caloric expenditure.
Weight stabilization: why multi-year follow-up makes a difference
Weight stabilization is not just a final phase of a program. It must be monitored over several years, with reassessment in case of weight regain. It is not the last step of a few months’ journey.
In practice, this means that a person who has reached their weight goal cannot simply “go back to their old life.” The maintenance phase requires as much attention as the weight loss phase. The mechanisms regulating appetite, particularly through insulin and other hormones, take time to recalibrate after significant fat mass loss.
Signals that warrant reassessment
Several indicators should raise alarms:
- A regain of more than a few kilos over several weeks, which may indicate a metabolic disorder rather than just a dietary slip.
- Persistent fatigue or recurrent cravings, often linked to insufficient protein or fiber intake.
- A change in life context (work stress, cessation of physical activity) that alters the energy balance without any change in diet.
The HAS emphasizes that weight regain is not a failure but a clinical signal requiring an adjustment of the pathway. This multi-year approach distinguishes sustainable weight loss from a simple episode of restriction followed by a return to initial weight.
The trap of online anti-obesity peptides
A recent phenomenon complicates the landscape: the online circulation of peptides presented as weight loss solutions. Semaglutide and tirzepatide, prescription medications in France, are increasingly trafficked online. Unregulated products, sometimes counterfeit, are sold without any medical follow-up.
Buying an anti-obesity peptide outside the medical circuit exposes individuals to real health risks: incorrect dosages, lack of prior diagnosis, unmonitored side effects. French recommendations remind that these treatments never replace structured nutritional and physical management.
Maintaining lost weight relies on the combination of several levers (diet, physical activity, medical follow-up) regularly adjusted over several years. It is this duration of follow-up, more than the initial choice of method, that predicts long-term outcomes.
